Home/Filings/4/0001384101-25-000044
4//SEC Filing

Febbo Phillip G. 4

Accession 0001384101-25-000044

CIK 0001384101other

Filed

Mar 9, 8:00 PM ET

Accepted

Mar 10, 4:44 PM ET

Size

4.9 KB

Accession

0001384101-25-000044

Insider Transaction Report

Form 4
Period: 2025-03-06
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
  • Award

    Common Stock

    2025-03-06+24,160106,700 total
Footnotes (1)
  • [F1]Restricted stock units awarded on March 6, 2025 vest 25% on March 2, 2026 and 1/16 per quarter thereafter subject to continuing employment of the Reporting Person on each vesting date.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001649245

Filing Metadata

Form type
4
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 4:44 PM ET
Size
4.9 KB